Femtobiomed Inc. (XKON:327610)
South Korea
· Delayed Price · Currency is KRW
890.00
+91.00 (11.39%)
At close: Mar 9, 2026
Femtobiomed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2018 | FY 2017 |
| Mar '26 Mar 6, 2026 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
| Debt / Equity Ratio | - | - | 0.03 |
| Net Debt / Equity Ratio | -0.31 | -0.31 | -0.74 |
| Net Debt / EBITDA Ratio | 0.30 | 0.30 | 1.82 |
| Net Debt / FCF Ratio | 0.26 | 0.26 | 1.66 |
| Asset Turnover | 0.22 | 0.22 | - |
| Inventory Turnover | 2.42 | 2.42 | - |
| Quick Ratio | 6.32 | 6.32 | 15.04 |
| Current Ratio | 12.25 | 12.25 | 17.18 |
| Return on Equity (ROE) | -74.10% | -74.10% | - |
| Return on Assets (ROA) | -41.65% | -41.65% | - |
| Return on Capital Employed (ROCE) | -108.10% | -108.10% | -45.30% |
| Buyback Yield / Dilution | - | -0.06% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.